Kbc Group Nv Moderna, Inc. Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Moderna, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 23,378 shares of MRNA stock, worth $642,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,378

Previous 44,461 47.42%

Holding current value

$642,661

Previous $1.26 Million 48.85%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$23.65 - $28.54 $498,612 - $601,708	-21,083 Reduced 47.42%	23,378 $645,000
Q1 2025 Apr 25, 2025	BUY	$28.35 - $47.53 $29,994 - $50,286	1,058 Added 2.44%	44,461 $1.26 Million
Q4 2024 Jan 22, 2025	SELL	$36.85 - $63.93 $1.44 Million - $2.49 Million	-38,943 Reduced 47.29%	43,403 $1.81 Million
Q3 2024 Nov 06, 2024	SELL	$63.64 - $125.14 $3.58 Million - $7.05 Million	-56,297 Reduced 40.61%	82,346 $5.5 Million
Q2 2024 Jul 17, 2024	SELL	$101.21 - $166.61 $38.5 Million - $63.5 Million	-380,888 Reduced 73.31%	138,643 $16.5 Million
Q1 2024 May 08, 2024	BUY	$85.37 - $115.44 $39.3 Million - $53.2 Million	460,560 Added 780.99%	519,531 $55.4 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $7.12 Million - $10.7 Million	-102,382 Reduced 63.45%	58,971 $5.87 Million
Q3 2023 Feb 15, 2024	SELL	$96.41 - $126.61 $9.28 Million - $12.2 Million	-96,216 Reduced 59.36%	65,861 $6.8 Million
Q2 2023 Feb 15, 2024	BUY	$118.5 - $160.53 $9.02 Million - $12.2 Million	76,130 Added 88.58%	162,077 $19.7 Million
Q2 2023 Jul 28, 2023	SELL	$118.5 - $160.53 $2.82 Million - $3.82 Million	-23,792 Reduced 12.85%	161,353 $19.6 Million
Q1 2023 Feb 14, 2024	BUY	$135.66 - $197.02 $11 Million - $16 Million	81,233 Added 77.35%	186,259 $28.6 Million
Q1 2023 May 04, 2023	BUY	$135.66 - $197.02 $13.5 Million - $19.6 Million	99,702 Added 116.69%	185,145 $28.4 Million
Q4 2022 Feb 14, 2024	BUY	$118.38 - $210.04 $2 Million - $3.55 Million	16,917 Added 19.2%	105,026 $18.9 Million
Q3 2022 Feb 15, 2024	BUY	$118.07 - $194.18 $3.19 Million - $5.24 Million	26,976 Added 45.74%	85,947 $10.2 Million
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $240,626 - $395,738	-2,038 Reduced 2.33%	85,443 $10.1 Million
Q2 2022 Feb 14, 2024	BUY	$117.13 - $176.59 $7.79 Million - $11.7 Million	66,507 Added 307.87%	88,109 $12.6 Million
Q2 2022 Jul 26, 2022	BUY	$117.13 - $176.59 $7.72 Million - $11.6 Million	65,879 Added 304.97%	87,481 $12.5 Million
Q1 2022 Feb 14, 2024	SELL	$126.46 - $235.05 $7.44 Million - $13.8 Million	-58,829 Reduced 73.14%	21,602 $3.72 Million
Q1 2022 May 06, 2022	SELL	$126.46 - $235.05 $7.44 Million - $13.8 Million	-58,829 Reduced 73.14%	21,602 $3.72 Million
Q4 2021 Feb 14, 2024	BUY	$225.82 - $368.51 $4.85 Million - $7.91 Million	21,460 Added 36.39%	80,431 $20.4 Million
Q4 2021 Feb 03, 2022	SELL	$225.82 - $368.51 $17.4 Million - $28.3 Million	-76,839 Reduced 48.86%	80,431 $20.4 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $10.2 Million - $22.2 Million	45,898 Added 41.21%	157,270 $60.5 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $2.06 Million - $3.72 Million	15,829 Added 16.57%	111,372 $26.2 Million
Q1 2021 Apr 26, 2021	BUY	$109.18 - $185.98 $4.8 Million - $8.17 Million	43,931 Added 85.12%	95,543 $12.5 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $3.37 Million - $8.72 Million	-51,330 Reduced 49.86%	51,612 $5.39 Million
Q3 2020 Oct 28, 2020	BUY	$54.34 - $94.85 $1.08 Million - $1.89 Million	19,952 Added 24.04%	102,942 $7.28 Million
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $2.46 Million - $6.64 Million	82,990 New	82,990 $5.33 Million

Others Institutions Holding MRNA

# of Institutions

859

Shares Held

266M

Call Options Held

28.5M

Put Options Held

34.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account